Imunoglucan

Immunoglucan is available in two pharmaceutical forms to meet the different needs of users:

Capsules: each capsule contains 100 mg of IMG® and 100 mg of vitamin C and is intended for oral administration for long-term support of the immune system.

Syrup (120 ml): each millilitre of solution contains 10 mg IMG® and 10 mg vitamin C. This liquid form is specially developed for children and adults who prefer this form of administration.

Immunoglucan is recommended in the following situations:

• For long-term support of the immune system
• During periods of convalescence, to accelerate the body's recovery after infections
• In conditions of physical and mental stress, including exams, intense training or excessive physical activity
• For children starting kindergarten or school, periods associated with increased exposure to infectious agents
• For adults and children aged 3 years and older, with a favourable safety profile.

The recommended dosage varies depending on the pharmaceutical form used:

• Capsules: 1-3 capsules per day, administered over a minimum period of 2-3 months for optimal effect, or as directed by a specialist
• Syrup: the dosage is based on body weight, according to the instructions on the packaging or the doctor's recommendations

Imunoglucan is not recommended for people with known hypersensitivity to any of the ingredients in the product.

Patients with autoimmune disorders or other severe chronic diseases should also consult a doctor before use.

For maximum effect, Imunoglucan should be taken over a longer period of time. It is recommended that it be taken between meals for optimal absorption of the active ingredients.

This product is a dietary supplement and should not replace a varied and balanced diet and a healthy lifestyle.

Imunoglucan has a favourable safety profile and adverse effects are rare. However, mild allergic reactions may occur in people who are sensitive to any of the ingredients.

If any unpleasant symptoms occur, it is recommended to discontinue use and consult a doctor.

Caution is advised when taking Imunoglucan concomitantly with immunosuppressants or other products that modulate the immune system, as well as with antihypertensive medicines.

It is recommended to consult a specialist before taking Imunoglucan to avoid possible interactions or undesirable effects.

To date, no cases of overdose with Imunoglucan have been reported. Taking an excessive dose of vitamin C may cause minor gastrointestinal disorders, such as diarrhoea or abdominal discomfort.

Follow the recommended doses to avoid any unpleasant symptoms.

Imunoglucan should be stored in a dry place, away from light and moisture, at temperatures below 25°C. Once opened, the syrup should be consumed within the period specified on the packaging. Keep out of the reach of children.

• ScienceDirect, Immunomodulatory effect of pleuran (β-glucan from Pleurotus ostreatus) in children with recurrent respiratory tract infections
• PubMed, Beta-(1,3/1,6)-D-glucan from Pleurotus ostreatus in the prevention of recurrent respiratory tract infections: An international, multicentre, open-label, prospective study
• ScienceDirect, Effect of a pleuran-based supplement on salivary IgA secretion in children with recurrent respiratory infections
• WebMD, Beta-glucans